Literature DB >> 27372842

Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease.

Coen van Kan1, Mart N van der Plas2, Herre J Reesink3, Reindert P van Steenwijk4, Jaap J Kloek5, Robert Tepaske6, Peter I Bonta4, Paul Bresser2.   

Abstract

BACKGROUND: Patients with chronic thromboembolic disease (CTED) may suffer from exercise intolerance without pulmonary hypertension at rest. Pulmonary endarterectomy (PEA) for symptomatic CTED results in improvement of symptoms and quality of life. Neither the pathophysiology of the exercise limitation nor the underlying mechanisms of the PEA-induced improvement have been studied previously.
OBJECTIVES: We studied hemodynamic and ventilatory responses upon exercise in 14 patients with CTED. After 1 year, we studied the underlying physiologic mechanisms of the PEA-induced symptomatic improvement.
METHODS: Cardiopulmonary exercise testing (CPET) was performed during right heart catheterization, and noninvasive CPET was performed 1 year postoperatively.
RESULTS: During exercise, we observed abnormal pulmonary vascular responses, that is, a steep mean pulmonary artery pressure/cardiac output (2.7 ± 1.2 mm Hg·min·L(-1)), and low pulmonary vascular compliance (2.8 ± 1.1 mL·mm Hg(-1)); mean pulmonary artery pressure/cardiac output slope correlated with dead-space ventilation (r = 0.586; P = .028) and ventilatory equivalents for carbon dioxide slope (r = .580; P = .030). Postoperatively, the improvement observed in exercise capacity was related to improvements in CPET-derived parameters pointing to restoration of right ventricle stroke volume response (oxygen pulse: 11.7 ± 3.1 to 13.3 ± 3.3; P = .027; heart rate response: 80.9 ± 12.4 to 72.0 ± 5.7; P = .003); and, indicating improved ventilatory efficiency, the ventilatory equivalents for carbon dioxide slope decreased from 38.2 ± 3.6 to 32.8 ± 7.0 (P = .014).
CONCLUSIONS: Patients with CTED showed an abnormal pulmonary vascular response to exercise and a decreased ventilatory efficiency. Responses after PEA point to restoration of right ventricle stroke volume response and ventilatory efficiency.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiopulmonary exercise test; chronic thromboembolic pulmonary hypertension; pulmonary endarterectomy; pulmonary hypertension; right heart catheterization

Mesh:

Substances:

Year:  2016        PMID: 27372842     DOI: 10.1016/j.jtcvs.2016.05.058

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Krittika Teerapuncharoen; Remzi Bag
Journal:  Lung       Date:  2022-05-29       Impact factor: 2.584

Review 2.  Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.

Authors:  Tom Verbelen; Laurent Godinas; Geert Maleux; Johan Coolen; Guido Claessen; Catharina Belge; Bart Meyns; Marion Delcroix
Journal:  Ann Cardiothorac Surg       Date:  2022-03

Review 3.  Pulmonary endarterectomy: technique and pitfalls.

Authors:  Stefan Guth; Eckhard Mayer; Diethard Prüfer; Christoph B Wiedenroth
Journal:  Ann Cardiothorac Surg       Date:  2022-03

4.  Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease.

Authors:  Christoph B Wiedenroth; Karen M Olsson; Stefan Guth; Andreas Breithecker; Moritz Haas; Jan-Christopher Kamp; Jan Fuge; Jan B Hinrichs; Fritz Roller; Christian W Hamm; Eckhard Mayer; Hossein A Ghofrani; Bernhard C Meyer; Christoph Liebetrau
Journal:  Pulm Circ       Date:  2017-12-28       Impact factor: 3.017

5.  Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.

Authors:  Manuel J Richter; Henning Gall; Gesa Wittkämper; Werner Seeger; Eckhard Mayer; Hossein A Ghofrani; Stefan Guth; Frank Reichenberger
Journal:  Pulm Circ       Date:  2017-05-12       Impact factor: 3.017

6.  Chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Marion Delcroix; Xavier Jais; Michael M Madani; Hiromi Matsubara; Eckhard Mayer; Takeshi Ogo; Victor F Tapson; Hossein-Ardeschir Ghofrani; David P Jenkins
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

7.  Pulmonology approach in the investigation of chronic unexplained dyspnea.

Authors:  Danilo Cortozi Berton; Nathalia Branco Schweitzer Mendes; Pedro Olivo-Neto; Igor Gorski Benedetto; Marcelo Basso Gazzana
Journal:  J Bras Pneumol       Date:  2021-02-08       Impact factor: 2.624

8.  Pulmonary endarterectomy for patients with chronic thromboembolic disease.

Authors:  Şehnaz Olgun Yıldızeli; Alper Kepez; Serpil Taş; Mehmed Yanartaş; Ali Fuad Durusoy; Atakan Erkılınç; Bülent Mutlu; Cihangir Kaymaz; Hasan Sunar; Bedrettin Yıldızeli
Journal:  Anatol J Cardiol       Date:  2018-04       Impact factor: 1.596

9.  Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.

Authors:  Kim A Ma; Susan R Kahn; Arash Akaberi; Carole Dennie; Christopher Rush; John T Granton; David Anderson; Philip S Wells; Marc A Rodger; Susan Solymoss; Michael J Kovacs; Lawrence Rudski; Avi Shimony; Paul Hernandez; Shawn D Aaron; Elena Pena; Gad Abikhzer; Andrew M Hirsch
Journal:  Res Pract Thromb Haemost       Date:  2018-06-17

Review 10.  Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium.

Authors:  Christopher A Thomas; Ryan J Anderson; David F Condon; Vinicio A de Jesus Perez
Journal:  Pulm Ther       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.